#1 Clinical Trials Search in Europe

Misoprostol

Misoprostol is a medication that has been extensively studied in clinical trials for various obstetric and gynecological applications. This article explores the use of misoprostol in clinical trials, focusing primarily on its role in labor induction and pregnancy termination. We’ll examine different formulations, dosages, and administration routes of misoprostol, as well as its effectiveness and safety profile in these medical procedures.

Table of Contents

What is Misoprostol?

Misoprostol is a medication that belongs to a class of drugs called prostaglandin analogs. It’s a synthetic version of prostaglandin E1, which is naturally produced in the body[1]. Misoprostol is known by several brand names, including Cytotec, Misotac, and Prostokos[1][2].

Uses of Misoprostol

Misoprostol is used in various medical situations, primarily related to obstetrics and gynecology. Here are its main uses:

  • Labor Induction: Misoprostol is commonly used to start labor in pregnant women. It helps soften and open the cervix (the neck of the womb), making it more favorable for delivery[3].
  • Prevention and Treatment of Postpartum Hemorrhage: This is bleeding after childbirth. Misoprostol can help prevent or treat excessive bleeding by causing the uterus to contract[4].
  • Management of Miscarriage: In cases of missed abortion (when a pregnancy has ended but the body hasn’t recognized it), misoprostol can be used to help expel the pregnancy tissue[5].
  • Cervical Ripening before IUD Insertion: For women who have had a cesarean section, misoprostol can be used to soften the cervix before inserting an intrauterine device (IUD)[1].

Administration Methods

Misoprostol can be administered in several ways, depending on the specific medical situation:

  • Oral: Tablets taken by mouth[3].
  • Sublingual: Tablets placed under the tongue to dissolve[6].
  • Vaginal: Tablets inserted into the vagina[2].
  • Buccal: Tablets placed between the cheek and gum to dissolve[5].
  • Rectal: Tablets inserted into the rectum[4].

The dosage and method of administration depend on the specific condition being treated and will be determined by your healthcare provider.

Effectiveness

Misoprostol has shown effectiveness in various clinical scenarios:

  • Labor Induction: Studies have shown that misoprostol can effectively induce labor within 24 hours of administration[3].
  • Postpartum Hemorrhage: Misoprostol has been found to be effective in reducing blood loss after childbirth, especially when combined with other treatments like oxytocin[4].
  • Cervical Ripening: For IUD insertion in women with previous cesarean sections, misoprostol has been shown to make the procedure easier and less painful[1].

Side Effects and Safety

Like all medications, misoprostol can cause side effects. Common side effects may include:

  • Nausea and vomiting
  • Diarrhea
  • Abdominal pain
  • Fever and chills
  • Headache

In obstetric use, there’s also a risk of uterine hyperstimulation (too many contractions), which can affect the baby’s heart rate. Your healthcare provider will monitor you closely when using this medication[3].

Comparison with Other Treatments

Misoprostol is often compared to or used in combination with other treatments:

  • Oxytocin: Another medication used to induce labor and prevent postpartum hemorrhage. Some studies have looked at combining misoprostol with oxytocin for better results[7].
  • Foley Catheter: A mechanical method of inducing labor. Some research has compared the effectiveness of misoprostol to the Foley catheter, or used them in combination[2][8].
  • Carbetocin: Another medication used to prevent postpartum hemorrhage. Studies have compared its effectiveness to misoprostol[4].

The choice between these treatments depends on various factors, including the specific medical situation, the patient’s health history, and the healthcare provider’s assessment.

Aspect Details
Formulations Angusta™ (25 μg), Cytotec® (200 μg), Misodel® (vaginal slow-release), oral titrated solutions
Administration Routes Oral, sublingual, vaginal
Dosages Varying from 20 μg/hour to 400 μg, depending on the study and purpose
Primary Uses Labor induction, cervical ripening, pregnancy termination, management of miscarriage
Key Outcomes Measured Time to delivery, vaginal delivery rates, cesarean section rates, adverse events
Safety Considerations Uterine hyperstimulation, fetal distress, maternal side effects
Comparison Studies Different dosages, formulations, and administration routes of misoprostol

FAQ

  • What is misoprostol and what is it used for in obstetrics? Misoprostol is a synthetic prostaglandin E1 analogue. In obstetrics, it is used for cervical ripening, labor induction, and medical management of miscarriage or pregnancy termination. It can also be used to treat postpartum hemorrhage.
  • How is misoprostol administered in clinical trials? In clinical trials, misoprostol is administered through various routes, including oral, sublingual, and vaginal. The dosage and frequency of administration vary depending on the specific purpose and study design.
  • What are the common formulations of misoprostol used in clinical trials? Common formulations include Angusta™ (25 μg dispersible tablets), Cytotec® (200 μg tablets), and Misodel® (vaginal slow-release misoprostol). Some trials also use oral titrated solutions of misoprostol.
  • What are the primary outcomes measured in misoprostol clinical trials? Primary outcomes often include the success rate of labor induction, time to delivery, vaginal delivery rates, cesarean section rates, and the occurrence of adverse events such as uterine hyperstimulation or fetal distress.
  • Are there any safety concerns associated with misoprostol use in clinical trials? Safety concerns monitored in clinical trials include uterine hyperstimulation, adverse events for both mother and infant, and the risk of uterine rupture. Trials also assess the drug's impact on fetal heart rate and Apgar scores.

Ongoing Clinical Trials on Misoprostol

  • Comparing hysteroscopic surgery to mifepristone and misoprostol treatment for early pregnancy loss in women under 10 weeks of pregnancy

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium

  • Study on Reducing Bleeding Risk in Fibroid Surgery Using Misoprostol for Patients Undergoing Myomectomy

    Recruiting

    1 1
    Investigated drugs:
    France

  • Comparison of Oxytocin versus Prostaglandins (Dinoprostone and Misoprostol) for Labor Induction in Women with Unfavorable Cervix After Initial Cervical Ripening

    Recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Study of Oral Misoprostol Combined with Osmotic Dilators for Labour Induction in Women with an Unprepared Cervix

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Czechia

  • Study Comparing Balloon with Oxytocin and Oral Misoprostol for Inducing Labor in First-Time Mothers with Premature Rupture of Membranes at Term

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

Glossary

  • Misoprostol: A synthetic prostaglandin E1 analogue used for various obstetric and gynecological purposes, including cervical ripening, labor induction, and management of miscarriage or pregnancy termination.
  • Cervical ripening: The process of softening, thinning, and dilating the cervix in preparation for labor and delivery.
  • Labor induction: The artificial initiation of labor before it begins naturally, often using medications or other medical interventions.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • AUC (Area Under the Curve): A measure used in pharmacokinetics to assess the total exposure to a drug over time.
  • Bioavailability: The proportion of a drug that enters the circulation when introduced into the body and is able to have an active effect.
  • Sublingual administration: A method of giving medication by placing it under the tongue to dissolve and absorb into the bloodstream.
  • Vaginal administration: A method of delivering medication directly into the vagina, often used in obstetrics and gynecology.
  • Titrated solution: A liquid form of medication where the concentration is carefully adjusted to deliver precise doses.
  • APGAR score: A quick test performed on newborns to evaluate their physical condition immediately after birth.
  • Cardiotochographic (CTG) monitoring: A method used to monitor fetal heart rate and uterine contractions during pregnancy and labor.
  • Uterine hyperstimulation: A condition where the uterus contracts too frequently or too strongly, potentially causing fetal distress.
  • Bishop score: A pre-labor scoring system used to assess the readiness of the cervix for labor induction.

References

  1. https://clinicaltrials.gov/study/NCT02141321
  2. https://clinicaltrials.gov/study/NCT01140971
  3. https://clinicaltrials.gov/study/NCT03866772
  4. https://clinicaltrials.gov/study/NCT03556852
  5. https://clinicaltrials.gov/study/NCT00892229
  6. https://clinicaltrials.gov/study/NCT02083107
  7. https://clinicaltrials.gov/study/NCT04560218
  8. https://clinicaltrials.gov/study/NCT02758340